A significant focus will be on the economic aspects of longevity, including private investment, venture capital perspectives, and the role of increased longevity in societal resilience and productivity.

Key topics include integrating science and policy, data sharing through the European Health Data Space, and recent advances in biomarkers, rejuvenation technologies, and biopsychosocial factors influencing aging.

The smaller population of the Baltic region offers a strategic testing ground for pilot schemes, regulatory innovations, and preventive programs that could serve as models for other aging societies.

The Baltic region is actively focusing on healthy longevity, with two major conferences scheduled in September 2025 in Riga and Vilnius to address aging, healthspan, and demographic challenges.

These conferences will feature international and regional experts discussing advancements in genetics, regenerative medicine, digital health, and regulatory pathways for emerging therapies, emphasizing multidisciplinary approaches.

With life expectancy around 76 years in Latvia and Lithuania but healthy life expectancy closer to 64 years, especially after COVID-19 declines, there is an urgent need to improve healthspan.

Ultimately, the conferences aim to elevate longevity from a scientific concept to a strategic priority in policy, investment, and cross-border collaboration, with success measured by tangible actions and partnerships.